{
    "Trade/Device Name(s)": [
        "Access hsTnI"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K222881",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172787"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "August 3, 2023",
    "Summary Letter Received Date": "August 3, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac troponin I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DxI Access Immunoassay Analyzers",
        "DxI 9000 Access Immunoassay Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle immunoassay",
        "Sandwich immunoenzymatic assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Access hsTnI chemiluminescent immunoassay for quantitative cardiac troponin I determination using DxI Access Immunoassay Analyzers",
    "Indications for Use Summary": "Quantitative determination of cardiac troponin I (cTnI) levels in human serum and plasma using DxI Access Immunoassay Analyzers to aid in the diagnosis of myocardial infarction (MI)",
    "fda_folder": "Clinical Chemistry"
}